Abstract:Background: Growing evidence on chronotherapy supports administering treatments according to endogenous biological rhythms.
Objectives: To evaluate whether the administration time of dupilumab affects its effectiveness in patients with atopic dermatitis (AD), by virtue of the circadian oscillations of immune system activity.
Methods: This retrospective study included all adult patients with AD treated with dupilumab from January 2020 to January 2024 at our unit. Data recorded at baseline (T0) and at the 16-week-treatment visit (T16) included itch severity, sleep disturbance, Eczema Area and Severity Index, Patient-Oriented Eczema Measure, Dermatology Life Quality Index, and immunoglobulin E levels. Therapeutic response was compared between two groups, based on injection time, that is, between 12:00 a.m. and 12:00 p.m. versus between 12:00 p.m. and 12:00 a.m.
Results: Fifty-three patients were included, of whom 21 took dupilumab between 12:00 a.m. and 12:00 p.m. and 32 between 12:00 p.m. and 12:00 a.m. All clinical parameters improved from T0 to T16, without significant differences between groups. However, there was a greater improvement in these parameters in subjects taking dupilumab between 12:00 a.m. and 12:00 p.m., compared with the others.
Conclusions: These preliminary results suggest a difference in therapeutic response to dupilumab based on the administration time, leading to potential optimization of its efficacy. Further studies on larger samples are needed.
Get full access to this article
View all access options for this article.
References
1.
PlikusMV, Van SpykEN, PhamK, et al.The circadian clock in skin: Implications for adult stem cells, tissue regeneration, cancer, aging, and immunity. J Biol Rhythms. 2015; 30(3):163–182; doi: 10.1177/0748730414563537
2.
SchettiniN, PacettiL, CorazzaM, et al.The Role of OX40-OX40L axis in the pathogenesis of atopic dermatitis. Dermatitis. 2024; doi: 10.1089/derm.2024.0058
FacherisP, JefferyJ, Del DucaE, et al.The translational revolution in atopic dermatitis: The paradigm shift from pathogenesis to treatment. Cell Mol Immunol. 2023; 20(5):448–474; doi: 10.1038/s41423-023-00992-4
5.
FaniaL, MorettaG, AntonelliF, et al.Multiple roles for cytokines in atopic dermatitis: From pathogenic mediators to endotype-specific biomarkers to therapeutic targets. Int J Mol Sci. 2022; 23(5):2684; doi: 10.3390/ijms23052684
6.
VaughnAR, ClarkAK, SivamaniRK, et al.Circadian rhythm in atopic dermatitis-Pathophysiology and implications for chronotherapy. Pediatr Dermatol. 2018; 35(1):152–157; doi: 10.1111/pde.13364
7.
AndoN, NakamuraY, AokiR, et al.Circadian gene clock regulates psoriasis-like skin inflammation in mice. J Invest Dermatol. 2015; 135(12):3001–3008; doi: 10.1038/jid.2015.316
8.
MillingS. It’s time to think about circadian rhythms. Immunology. 2020; 161(4):259–260; doi: 10.1111/imm.13284
9.
ManfrediniR, CappadonaR, TiseoR, et al.Light, circadian rhythms and health. In CapolongoS, RebecchiA (eds) Therapeutic Landscape Design, SpringerBriefs in Applied Sciences and Technology. Springer, Cham, 2023, pp.81–92. doi:10.1007/978-3-031-09439-2
10.
LubovJE, CvammenW, KempMG. The impact of the circadian clock on skin physiology and cancer development. Int J Mol Sci. 2021; 22(11):6112; doi: 10.3390/ijms22116112
11.
ScheiermannC, GibbsJ, InceL, et al.Clocking in to immunity. Nat Rev Immunol. 2018; 18(7):423–437; doi: 10.1038/s41577-018-0008-4
12.
DimitrovS, LangeT, NohroudiK, et al.Number and function of circulating human antigen presenting cells regulated by sleep. Sleep. 2007; 30(4):401–411; doi: 10.1093/sleep/30.4.401
13.
YosipovitchG, GoonAT, WeeJ, et al.Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol. 2002; 41(4):212–216; doi: 10.1046/j.1365-4362.2002.01460.x
14.
LéviFA, OkyarA, HadadiE, et al.Circadian regulation of drug responses: Toward sex-specific and personalized chronotherapy. Annu Rev Pharmacol Toxicol. 2024; 64:89–114; doi: 10.1146/annurev-pharmtox-051920-095416
15.
De GiorgiA, Mallozzi MenegattiA, FabbianF, et al.Circadian rhythms and medical diseases: Does it matter when drugs are taken? Eur J Intern Med. 2013; 24(8):698–706; doi: 10.1016/j.ejim.2013.03.019
16.
ManfrediniR, FabbianF. A pill at bedtime, and your heart is fine? Bedtime hypertension chronotherapy: An opportune and advantageous inexpensive treatment strategy. Sleep Med Rev. 2017; 33:1–3; doi: 10.1016/j.smrv.2016.08.006
17.
UrsiniF, De GiorgiA, D’OnghiaM, et al.Chronobiology and chronotherapy in inflammatory joint diseases. Pharmaceutics. 2021; 13(11):1832; doi: 10.3390/pharmaceutics13111832
18.
De GiorgiA, FabbianF, Di SimoneE, et al.OUTCOME-INTMED-COV19 Study Collaborators. Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy. Eur Rev Med Pharmacol Sci. 2020; 24(15):8219–8225; doi: 10.26355/eurrev_202008_22511
19.
LandréT, KarabouéA, BuchwaldZS, et al.Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: A study-level meta-analysis. ESMO Open. 2024; 9(2):102220; doi: 10.1016/j.esmoop.2023.102220
20.
LangeT, DimitrovS, FehmHL, et al.Sleep-like concentrations of growth hormone and cortisol modulate type1 and type2 in-vitro cytokine production in human T cells. Int Immunopharmacol. 2006; 6(2):216–225; doi: 10.1016/j.intimp.2005.08.006
21.
KimTK, LinZ, TidwellWJ, et al.Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro. Mol Cell Endocrinol. 2015; 404:1–8; doi: 10.1016/j.mce.2014.07.024
22.
DuanJ, GreenbergEN, KarriSS, et al.The circadian clock and diseases of the skin. FEBS Lett. 2021; 595(19):2413–2436; doi: 10.1002/1873-3468.14192
23.
LuberAJ, EnsanyatSH, ZeichnerJA. Therapeutic implications of the circadian clock on skin function. J Drugs Dermatol. 2014; 13(2):130–134; doi: 10.1177/0748730414563537
24.
ThokeJ, PatelS, MajumdarA. Understanding skin chronobiology to unveil and transform dermal chronotherapeutics: Paving the way for the future. Chronobiol Med. 2021; 3(1):8–15; doi: 10.33069/cim.2020.0032
25.
SilverbergJI, ThyssenJP, FahrbachK, et al.Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: A systematic literature review and network meta-analysis. J Eur Acad Dermatol Venereol. 2021; 35(9):1797–1810; doi: 10.1111/jdv.17351
26.
JaworekAK, SzepietowskiJC, HałubiecP, et al.Melatonin as an antioxidant and immunomodulator in atopic dermatitis-a new look on an old story: A review. Antioxidants (Basel). 2021; 10(8):1179; doi: 10.3390/antiox10081179
27.
RusanovaI, Martínez-RuizL, FloridoJ, et al.Protective effects of melatonin on the skin: Future perspectives. Int J Mol Sci. 2019; 20(19):4948; doi: 10.3390/ijms20194948
28.
LiuL, LabaniN, CeconE, et al.Melatonin target proteins: Too many or not enough? Front Endocrinol (Lausanne). 2019; 10:791; doi: 10.3389/fendo.2019.00791
29.
SlominskiAT, HardelandR, ZmijewskiMA, et al.Melatonin: A cutaneous perspective on its production, metabolism, and functions. J Invest Dermatol. 2018; 138(3):490–499; doi: 10.1016/j.jid.2017.10.025
30.
XiongJ, WangZ, CaoJ, et al.Melatonin mediates monochromatic light-induced proliferation of T/B lymphocytes in the spleen via the membrane receptor or nuclear receptor. Poult Sci. 2020; 99(9):4294–4302; doi: 10.1016/j.psj.2020.06.008
31.
DaiJ, ChooMK, ParkJM, et al.Topical ROR inverse agonists suppress inflammation in mouse models of atopic dermatitis and acute irritant dermatitis. J Invest Dermatol. 2017; 137(12):2523–2531; doi: 10.1016/j.jid.2017.07.819
32.
BertinoL, GuarneriF, CannavòSP, et al.Oxidative stress and atopic dermatitis. Antioxidants (Basel). 2020; 9(3):196; doi: 10.3390/antiox9030196
33.
ManninoG, CaradonnaF, CruciataI, et al.Melatonin reduces inflammatory response in human intestinal epithelial cells stimulated by interleukin-1β. J Pineal Res. 2019; 67(3):e12598; doi: 10.1111/jpi.12598
34.
ShinIS, ParkJW, ShinNR, et al.Melatonin reduces airway inflammation in ovalbumin-induced asthma. Immunobiology. 2014; 219(12):901–908; doi: 10.1016/j.imbio.2014.08.004
35.
ChristP, SowaAS, FroyO, et al.The circadian clock drives mast cell functions in allergic reactions. Front Immunol. 2018; 9:1526; doi: 10.3389/fimmu.2018.01526
36.
MoritaH, MoroK, KoyasuS. Innate lymphoid cells in allergic and nonallergic inflammation. J Allergy Clin Immunol. 2016; 138(5):1253–1264; doi: 10.1016/j.jaci.2016.09.011
37.
HalimTY, MacLarenA, RomanishMT, et al.Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity. 2012; 37(3):463–474; doi: 10.1016/j.immuni.2012.06.012
38.
HammadH, LambrechtBN. Barrier epithelial cells and the control of type 2 immunity. Immunity. 2015; 43(1):29–40; doi: 10.1016/j.immuni.2015.07.007
39.
LiZ, RadinA, LiM, et al.Pharmacokinetics, pharmacodynamics, safety, and tolerability of dupilumab in healthy adult subjects. Clin Pharmacol Drug Dev. 2020; 9(6):742–755; doi: 10.1002/cpdd.798
40.
LongJE, DraysonMT, TaylorAE, et al.Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial. Vaccine. 2016; 34(24):2679–2685; doi: 10.1016/j.vaccine.2016.04.032Erratum in: Vaccine. 2016 Sep 14;34(40):4842. doi: 10.1016/j.vaccine.2016.08.031
41.
ZhangH, LiuY, LiuD, et al.Time of day influences immune response to an inactivated vaccine against SARS-CoV-2. Cell Res. 2021; 31(11):1215–1217; doi: 10.1038/s41422-021-00541-6
42.
de BreeLCJ, MouritsVP, KoekenVA, et al.Circadian rhythm influences induction of trained immunity by BCG vaccination. J Clin Invest. 2020; 130(10):5603–5617; doi: 10.1172/JCI133934
43.
HeidariS, BaborTF, De CastroP, et al.Sex and Gender Equity in Research: Rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev. 2016; 1:2; doi: 10.1186/s41073-016-0007-6
44.
PigazzaniF, DyarKA, MorantSV, et al.Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: The Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study. EClinicalMedicine. 2024; 72:102633; doi: 10.1016/j.eclinm.2024.102633
